Risk factors for EUS-guided radiofrequency ablation adverse events in patients with pancreatic neoplasms: a large national French study (RAFPAN study).
Napoléon B, Lisotti A, Caillol F, Gasmi M, Ah-Soune P, Belle A, Charachon A, Cholet F, Eyraud PY, Grandval P, Gonzalez JM, Habersetzer F, Koch S, Le Rhun M, Mangialavori L, Musquer N, Palazzo M, Poincloux L, Privat J, Sportes A, Stouvenot M, Subtil C, Thomassin L, Vanbiervliet G, Vidal G, Vuitton L, Giovannini M, Barthet M.
Napoléon B, et al. Among authors: gasmi m.
Gastrointest Endosc. 2023 Sep;98(3):392-399.e1. doi: 10.1016/j.gie.2023.04.003. Epub 2023 Apr 12.
Gastrointest Endosc. 2023.
PMID: 37059368